New and Generic Drug Approvals from FDA

Published on April 16, 2004 at 8:45 PM · No Comments

New and Generic Drug Approvals

Apidra (insulin glulisine [rDNA origin]) Injection, Aventis Pharmaceutal Inc.
Diazepam Injection, Parenta Pharmaceuticals
Dopram (doxapram hydrochloride) Injection, Baxter Healthcare
Fosamax (alendronate sodium) Tablets & Oral Solution, Merck
Intralipid I.V. Fat Emulsion, Fresenius Kabi
Mylotarg (Gemtuzumab Ozogamicin) Injection, Wyeth Pharmaceuticals
Thallous Chloride TI-201 Injection USP, Mallinckrodt Inc.
Zelnorm (tegaserod maleate) Tablets, Novartis Pharmaceuticals Corporation

838fe520-e827-46ae-83ce-c2f96411e2a3|0|.0

Posted in: Pharmaceutical News

Tags: Diazepam, Fosamax (alendronate sodium), Generic Drug, Insulin

Nanotechnology might provide greater efficacy of medicines for brain diseaseTechnology has been developed within Top Institute Pharma that helps medicines be absorbed quicker i...
Pharmaceutical Care Management Association response to New York Times article on biotech medicine costsThe Pharmaceutical Care Management Association (PCMA) issued the following statement today regarding...
Treatment with zoledronic acid effective in reducing fractures in women with postmenopausal osteoporosisA treatment for osteoporosis delivered once a year is as effective as current monthly or weekly oste...
Parents oblivious to their children's weight problemsTwo new studies show that many children are at high risk for diabetes and premature heart disease, a...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.